Lipid-lowering drugs.
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003084:Colestipol / Q000627:therapeutic use; D003918:Dextrothyroxine / Q000627:therapeutic use; D015248:Gemfibrozil; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008074:Lipoproteins / Q000097:blood; D009355:Neomycin / Q000627:therapeutic use; D009525:Niacin / Q000627:therapeutic use; D010421:Pentanoic Acids / Q000627:therapeutic use; D011341:Probucol / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D010421:Pentanoic Acids; D014280:Triglycerides; D002792:Cholestyramine Resin; D009525:Niacin; D003918:Dextrothyroxine; D002994:Clofibrate; D009355:Neomycin; D003084:Colestipol; D011341:Probucol; D015248:Gemfibrozil